ZimVie (ZimVie) Risk Assessment

View and export this data going back to 2022. Start your Free Trial

What is ZimVie Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of ZimVie is: No Data: Cannot be evaluated.

Competitive Comparison of ZimVie's Risk Assessment

For the Medical Devices subindustry, ZimVie's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ZimVie's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Risk Assessment distribution charts can be found below:

* The bar in red indicates where ZimVie's Risk Assessment falls into.

ZimVie (NAS:ZIMV) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

ZimVie Risk Assessment Related Terms

Thank you for viewing the detailed overview of ZimVie's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

ZimVie (ZimVie) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

O23:Germany

Address

10225 Westmoor Drive, Westminster, CO, USA, 80021

Website

https://www.zimvie.com

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Executives

Camber Capital Management Lp	10 percent owner	101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali	director, officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc.	10 percent owner	345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz	director	MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar	director	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec	director	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider	officer: Chief Accounting Officer	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021